Literature DB >> 21280087

γ-Secretase component presenilin is important for microglia β-amyloid clearance.

Dorit Farfara1, Dorit Trudler, Niva Segev-Amzaleg, Ronit Galron, Reuven Stein, Dan Frenkel.   

Abstract

OBJECTIVE: The cleavage of amyloid precursor protein by γ-secretase is an important aspect of the pathogenesis of Alzheimer's disease. γ-Secretase also cleaves other membrane proteins (eg, Notch), which control cell development and homeostasis. Presenilin 1 and 2 are considered important determinants of the γ-secretase catalytic site. Our aim was to investigate whether γ-secretase can be important for microglial phagocytosis of Alzheimer's disease β-amyloid.
METHODS: We investigated the role of γ-secretase in microglia activity toward β-amyloid phagocytosis in cell culture using γ-secretase inhibitors and small hairpin RNA and presenilin-deficient mice.
RESULTS: We found that γ-secretase inhibitors impair microglial activity as measured in gene expression, protein levels, and migration ability, which resulted in a reduction of soluble β-amyloid phagocytosis. Moreover, microglia deficient in presenilin 1 and 2 showed impairment in phagocytosis of soluble β-amyloid. Dysfunction in the γ-secretase catalytic site led to an impairment in clearing insoluble β-amyloid from brain sections taken from an Alzheimer's disease mouse model when compared to microglia from wild-type mice.
INTERPRETATION: We suggest for the first time, a dual role for γ-secretase in Alzheimer's disease. One role is the cleavage of the amyloid precursor protein for pathologic β-amyloid production and the other is to regulate microglia activity that is important for clearing neurotoxic β-amyloid deposits. Further studies of γ-secretase-mediated cellular pathways in microglia may provide useful insights into the development of Alzheimer's disease and other neurodegenerative diseases, providing future avenues for therapeutic intervention.
Copyright © 2010 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21280087     DOI: 10.1002/ana.22191

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

Review 1.  Myeloid Cells in the Central Nervous System.

Authors:  Jasmin Herz; Anthony J Filiano; Ashtyn Smith; Nir Yogev; Jonathan Kipnis
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

2.  Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits.

Authors:  Dorit Farfara; Emily Feierman; Allison Richards; Alexey S Revenko; Robert A MacLeod; Erin H Norris; Sidney Strickland
Journal:  Glia       Date:  2019-03-18       Impact factor: 7.452

3.  Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage.

Authors:  Patrick Wunderlich; Konstantin Glebov; Nadja Kemmerling; Nguyen T Tien; Harald Neumann; Jochen Walter
Journal:  J Biol Chem       Date:  2013-09-27       Impact factor: 5.157

4.  Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice.

Authors:  Darrell Sawmiller; Ahsan Habib; Song Li; Donna Darlington; Huayan Hou; Jun Tian; R Douglas Shytle; Adam Smith; Brian Giunta; Takashi Mori; Jun Tan
Journal:  J Neuroimmunol       Date:  2016-09-01       Impact factor: 3.478

5.  Low-level laser therapy ameliorates disease progression in a mouse model of Alzheimer's disease.

Authors:  Dorit Farfara; Hana Tuby; Dorit Trudler; Ella Doron-Mandel; Lidya Maltz; Robert J Vassar; Dan Frenkel; Uri Oron
Journal:  J Mol Neurosci       Date:  2014-07-04       Impact factor: 3.444

6.  Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease.

Authors:  Patrick J Cimino; Yue Yang; Xianwu Li; Jake F Hemingway; Makenzie K Cherne; Shawn B Khademi; Yoshinori Fukui; Kathleen S Montine; Thomas J Montine; C Dirk Keene
Journal:  Exp Mol Pathol       Date:  2013-01-11       Impact factor: 3.362

7.  Activated cyclin-dependent kinase 5 promotes microglial phagocytosis of fibrillar β-amyloid by up-regulating lipoprotein lipase expression.

Authors:  Yuanhui Ma; Jintao Bao; Xuyang Zhao; Hongyan Shen; Junniao Lv; Shuaipeng Ma; Xuefei Zhang; Zeyang Li; Shuxin Wang; Qingsong Wang; Jianguo Ji
Journal:  Mol Cell Proteomics       Date:  2013-07-01       Impact factor: 5.911

8.  Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).

Authors:  Paloma Bermejo-Bescós; Sagrario Martín-Aragón; Karim Jiménez-Aliaga; Juana Benedí; Emanuela Felici; Pedro Gil; José Manuel Ribera; Angel María Villar
Journal:  Neurochem Res       Date:  2013-04-11       Impact factor: 3.996

9.  Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis.

Authors:  Mariko Noda; Akio Suzumura
Journal:  Int J Alzheimers Dis       Date:  2012-05-14

10.  Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.

Authors:  Amanda Sierra; Oihane Abiega; Anahita Shahraz; Harald Neumann
Journal:  Front Cell Neurosci       Date:  2013-01-30       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.